HIGHLIGHTS
- who: Florence Roufosse from the Amerimmune, United States have published the research work: Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome, in the Journal: (JOURNAL)
SUMMARY
Included six domains, each representing a single commonlyreported HES symptom category; abdominal pain/bloating, breathing symptoms (e_g, shortness of breath, wheeze), chills/sweats, muscle/joint pain, nasal/sinus symptoms (e_g, congestion, runny nose), and skin symptoms (e_g, itchiness, rash, hives). Subsequently, patients completed ratings for all six domains each evening in an eDiary, recalling the worst symptom experience over the previous 24 hours . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.